ASIA CEO Community

Wilson is currently Chief Financial Officer of Tessa Therapeutics. Wilson has over 25 years of experience in accounting and finance, compliance and corporate leadership at both public and private companies. At Tessa, Wilson oversees the overall financial management, investor relations, legal, and business development strategy.
Prior to Tessa, Wilson served as EVP and CFO at Apollomics Inc. where he led the efforts to complete a US$124 million Series C round which later resulted in a SPAC listing on Nasdaq scheduled for early 2023. Prior to Apollomics, Wilson was CFO at KBP Biosciences, and served as SVP and CFO at SciClone Pharmaceuticals, Inc. (formerly NASDAQ: SCLN, now HKSE:6600) where he led the sale of SciClone to a private equity firm for over US$600 million. Prior to SciClone, Wilson worked for Velti Plc (formerly NASDAQ: VELT) as CFO where he took Velti on an IPO and a follow-on offering in the US raising over US$340 million. Prior to Velti Plc, Wilson served as CFO at AXT, Inc. (NASDAQ: AXTI). Wilson started his career with KPMG Los Angeles and had secondment experience in Hong Kong and Beijing.
Wilson has been a California certified public accountant since 1994. He has also been a certified director of corporate governance from the executive program of UCLA John E. Anderson Graduate School of Management since 2005. He holds a B.A. in Economics-Business from UCLA.
On the family front, Wilson is married (to Fiona) with an adult daughter (Allison) and two young sons (“Ando” and Anson). Wilson and his family moved to Singapore in September 2022 from the San Francisco Bay Area.